Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,396 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of anifrolumab on systemic lupus erythematosus patients with serological manifestations: A post hoc analysis of the Japan subgroup of the TULIP-2 Trial.
Tanaka Y, Atsumi T, Okada M, Miyamura T, Ishii T, Nishiyama S, Matsumura R, Hayashi N, Matsumoto T, Yabe-Wada T, Yamaguchi Y, Abreu G, Lindholm C, Takeuchi T. Tanaka Y, et al. Mod Rheumatol. 2025 Jan 17:roae111. doi: 10.1093/mr/roae111. Online ahead of print. Mod Rheumatol. 2025. PMID: 39821415
A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation.
Ohira M, Imaoka Y, Sato K, Imaoka K, Bekki T, Yano T, Nakano R, Sakai H, Kuroda S, Tahara H, Ide K, Kobayashi T, Tanaka Y, Tanaka J, Ohdan H. Ohira M, et al. Among authors: tanaka y. PLoS One. 2025 Jan 16;20(1):e0313102. doi: 10.1371/journal.pone.0313102. eCollection 2025. PLoS One. 2025. PMID: 39820189 Free article. Clinical Trial.
15,396 results
You have reached the last available page of results. Please see the User Guide for more information.